Methodology that is not complete, as well as discrepancies regarding the proposed mode of action of lipoxin A4, are significant weaknesses.
A 4-week vancomycin pulse and taper regimen may be a safe and effective strategy to delay or prevent Clostridioides difficile ...
A new study published in the Journal of the American Medical Association revealed that a 4-week vancomycin pulse and taper ...
By Dennis Thompson HealthDay ReporterTHURSDAY, April 9, 2026 (HealthDay News) — Prompt treatment with a fecal transplant can ...
A new study from the University of Minnesota Medical School demonstrated that fecal microbiota transplantation (FMT) can rapidly reverse systemic inflammation and improve survival in patients with ...
University of California San Diego researchers have developed a new tool for understanding and modifying any microbiome, including the human microbiome. The approach, called Microbial Interaction and ...
Affecting roughly half a million Americans each year, bacterial infections caused by Clostridioides difficile—commonly known as C. diff—are a serious and persistent problem for patients and hospitals ...
If you suffer from acid reflux or GERD, you might have been advised to take acid reducers. However, Dr Sood warns that ...
Vedanta Biosciences is a late clinical-stage biopharmaceutical company developing a new category of microbiome-based oral therapies for gastrointestinal diseases. Vedanta's lead program, VE303, is ...
Antibiotics can disrupt the healthy bacteria in your gut. Discover four different ways you can help protect your gut health ...
After biting into a chicken bone hidden inside a burrito, a routine dental infection led to antibiotic treatment that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results